Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance Database

MLA

Kenta Yamaoka, et al. “Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance Database.” Oncology, vol. 100, Jan. 2022, pp. 413–18. EBSCOhost, https://doi.org/10.1159/000524806.

APA

Kenta Yamaoka, Masaki Fujiwara, Mayako Uchida, Yoshihiro Uesawa, Nobuyuki Muroi, & Tadashi Shimizu. (2022). Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance Database. Oncology, 100, 413–418. https://doi.org/10.1159/000524806

Chicago

Kenta Yamaoka, Masaki Fujiwara, Mayako Uchida, Yoshihiro Uesawa, Nobuyuki Muroi, and Tadashi Shimizu. 2022. “Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance Database.” Oncology 100 (January): 413–18. doi:10.1159/000524806.